Literature DB >> 26057972

Accelerating innovation in rapid diagnostics and targeted antibacterials.

Thomas J Hwang1, John H Powers2, Daniel Carpenter3, Aaron S Kesselheim4.   

Abstract

Mesh：

Year:  2015        PMID： 26057972     DOI： 10.1038/nbt.3251

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009.

Authors:  Kevin Outterson; John H Powers; Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Aaron S Kesselheim
Journal:  J Law Med Ethics       Date:  2013       Impact factor: 1.718

2.  The potential risks of expedited approval of drugs for acute bacterial infections.

Authors:  James S Floyd; Bruce M Psaty
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

3.  Improving antibiotic markets for long-term sustainability.

Authors:  Aaron S Kesselheim; Kevin Outterson
Journal:  Yale J Health Policy Law Ethics       Date:  2011

4.  Antibacterials for any target.

Authors:  Lynn L Silver
Journal:  Nat Biotechnol       Date:  2014-11       Impact factor: 54.908

Review 5.  Mandatory disclaimers on dietary supplements do not reliably communicate the intended issues.

Authors:  Aaron S Kesselheim; John Connolly; James Rogers; Jerry Avorn
Journal:  Health Aff (Millwood)       Date:  2015-03       Impact factor: 6.301

6.  Paying for innovation: reimbursement incentives for antibiotics.

Authors:  Thomas J Hwang; Daniel Carpenter; Aaron S Kesselheim
Journal:  Sci Transl Med       Date:  2015-02-25       Impact factor: 17.956

7.  New FDA breakthrough-drug category--implications for patients.

Authors:  Jonathan J Darrow; Jerry Avorn; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

8.  Target small firms for antibiotic innovation.

Authors:  Thomas J Hwang; Daniel Carpenter; Aaron S Kesselheim
Journal:  Science       Date:  2014-05-30       Impact factor: 47.728

9.  Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

Authors:  Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883
  9 in total
  3 in total

1.  Why microbial diagnostics need more than money.

Authors:  Mark Kessel
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

2.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

3.  Veterinary Diagnostic Practice and the Use of Rapid Tests in Antimicrobial Stewardship on UK Livestock Farms.

Authors:  Henry Buller; Katie Adam; Alison Bard; Ann Bruce; Kin Wing Ray Chan; Stephen Hinchliffe; Lisa Morgans; Gwen Rees; Kristen K Reyher
Journal:  Front Vet Sci       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.